Krka reaches out-of-court settlement for donepezil in Norway
This article was originally published in Scrip
Executive Summary
Krka of Slovenia has reached an out-of-court settlement with Eisai for donepezil in Norway. Under the terms of the settlement, it will receive €1.6 million and continue marketing its product for the treatment of Alzheimer's disease in the country.